FI882421A0 - 5-fenyl-1,2,3a,4,5,9b-hexahydro-3h -benz(e)indol, deras framstaellning och anvoendning som laekemedel. - Google Patents

5-fenyl-1,2,3a,4,5,9b-hexahydro-3h -benz(e)indol, deras framstaellning och anvoendning som laekemedel.

Info

Publication number
FI882421A0
FI882421A0 FI882421A FI882421A FI882421A0 FI 882421 A0 FI882421 A0 FI 882421A0 FI 882421 A FI882421 A FI 882421A FI 882421 A FI882421 A FI 882421A FI 882421 A0 FI882421 A0 FI 882421A0
Authority
FI
Finland
Prior art keywords
hexahydro
phenyl
anvoendning
indol
benzene
Prior art date
Application number
FI882421A
Other languages
English (en)
Other versions
FI882421A (fi
FI88154B (fi
FI88154C (fi
Inventor
Gerd Steiner
Walter Himmele
Ernst Buschmann
Hans-Juergen Teschendorf
Harald Weifenbach
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI882421A0 publication Critical patent/FI882421A0/fi
Publication of FI882421A publication Critical patent/FI882421A/fi
Publication of FI88154B publication Critical patent/FI88154B/fi
Application granted granted Critical
Publication of FI88154C publication Critical patent/FI88154C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
FI882421A 1987-05-23 1988-05-23 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-fenyl-1,2,3a,4,5,9b-hexahydro-3h-bens/e/indoler FI88154C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3717395 1987-05-23
DE19873717395 DE3717395A1 (de) 1987-05-23 1987-05-23 5-phenyl-1,2,3a,4,5,9b-hexahydro-3h-benz(e) indole, ihre herstellung und verwendung als arzneimittel

Publications (4)

Publication Number Publication Date
FI882421A0 true FI882421A0 (fi) 1988-05-23
FI882421A FI882421A (fi) 1988-11-24
FI88154B FI88154B (fi) 1992-12-31
FI88154C FI88154C (fi) 1993-04-13

Family

ID=6328243

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882421A FI88154C (fi) 1987-05-23 1988-05-23 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-fenyl-1,2,3a,4,5,9b-hexahydro-3h-bens/e/indoler

Country Status (8)

Country Link
US (1) US4877807A (fi)
EP (1) EP0292819B1 (fi)
JP (1) JPH01117862A (fi)
AT (1) ATE74593T1 (fi)
CA (1) CA1311762C (fi)
DE (2) DE3717395A1 (fi)
ES (1) ES2032312T3 (fi)
FI (1) FI88154C (fi)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4930836B1 (fi) * 1971-07-22 1974-08-16
US4595688A (en) * 1983-06-23 1986-06-17 Mcneilab, Inc. Hexahydropyrrolo[2,1-a]isoquinoline derivatives and antidepressant use thereof
US4719216A (en) * 1983-06-23 1988-01-12 Mcneilab, Inc. Hexahydropyrrolo(2,1-A)isoquinoline derivatives as antidepressants
ZA844402B (en) * 1983-06-23 1986-01-29 Mcneil Pharmaceutical Hexahydropyrrolo(2,1-a)isoquinoline derivatives
US4678791A (en) * 1985-05-07 1987-07-07 Pennwalt Corporation 6-phenyl-1,2-3,4,4a,5-6,10b-octahydrobenz(h)isoquinolines useful for treating depression
DE3537075A1 (de) * 1985-10-18 1987-04-23 Bayer Ag Verfahren zur herstellung von clausenamid
DE3632589A1 (de) * 1985-10-18 1987-04-23 Bayer Ag Verfahren zur herstellung von (gamma)-butyrolactamen

Also Published As

Publication number Publication date
FI882421A (fi) 1988-11-24
EP0292819A3 (en) 1989-07-12
ATE74593T1 (de) 1992-04-15
DE3869830D1 (de) 1992-05-14
JPH01117862A (ja) 1989-05-10
FI88154B (fi) 1992-12-31
EP0292819B1 (de) 1992-04-08
DE3717395A1 (de) 1988-12-08
EP0292819A2 (de) 1988-11-30
CA1311762C (en) 1992-12-22
FI88154C (fi) 1993-04-13
US4877807A (en) 1989-10-31
ES2032312T3 (es) 1993-02-01

Similar Documents

Publication Publication Date Title
DK0775129T3 (da) 3-Benzoylbenzofuranderivater som thyroidhormonantagonister
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
BR9503582A (pt) Composto composiçao farmaceutica utilizaçao e método de tratamento de um ser humano
HUT40790A (en) Process for producing 2-/4-benzoyl-1-piperidinyl/-1-phenyl-alkanol derivatives and pharmaceutical compositions containing them
PT100620A (pt) Derivados de tetra-hidrocarbazol, seu uso e preparacao e composicoes farmaceuticas que os contem
NO167088C (no) Nye 5-alkoxy-2,4 diaminoalkylbenzener saavel som haarfarvemiddel med 5-alkoxy-2,4-diamino-alkylbenzen.
DE69231445D1 (de) Triazole enthaltende antifungizide mittel
BR8202861A (pt) Composto composicao farmaceutica processo para baixar a pressao sanguinea de seres humanos processo para preparar um composto e process para preparar uma composicao farmaceutica
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
FR2798126B1 (fr) Heteroaryloxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
DE69104475D1 (de) Harnstoffderivate, ihre herstellung und deren enthaltende arzneimittel.
AR020773A1 (es) Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto
FI882421A0 (fi) 5-fenyl-1,2,3a,4,5,9b-hexahydro-3h -benz(e)indol, deras framstaellning och anvoendning som laekemedel.
ES2165410T3 (es) Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ATE16384T1 (de) Phenylpiperazinyl-propanole von hetarylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
FI872997A0 (fi) Amidderivat.
ATE245986T1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
AU7532787A (en) New derivatives of 2,6-piperazinedione, their preparation process and the pharmaceutical compositions containing them
NO166179C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkyl -4h-1,2,4-triazolderivater.
IL70103A (en) 4-(6,7-dimethoxyquinazolin-4-yl)-semicarbazides,their preparation and pharmaceutical compositions containing them
HU894471D0 (en) Process for the preparation of 15-amino-20,21-dinor-eburnamenine derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BASF AKTIENGESELLSCHAFT